Sanofi | SNY - Trade Debtors




Sanofi reported 8.8B in Trade Debtors for its fiscal quarter ending in June of 2024.

Trade Debtors Change Date
AbbVie USD 11.47B 252M Sep/2024
Amgen USD 6.78B 535M Dec/2024
AstraZeneca USD 14.83B 1.28B Dec/2024
Bristol-Myers Squibb USD 14.9B 251M Sep/2024
Canopy Growth CAD 41.86M 9.03M Sep/2024
Corcept Therapeutics USD 59.72M 5.88M Sep/2024
Drreddys Laboratories INR 88.44B 7.35B Sep/2024
Eli Lilly USD 12.05B 941.5M Sep/2024
Galapagos EUR 87.36M 133K Dec/2024
Genmab DKK 6.69B 381M Dec/2024
GlaxoSmithKline GBP 7.32B 542M Dec/2024
Glaxosmithkline GBP 7.87B 89M Sep/2024
Indivior 271M 10M Sep/2024
J&J USD 16.17B 380M Sep/2024
Merck USD 12.54B 419M Sep/2024
Novartis USD 9B 854M Dec/2024
Novartis USD 8.15B 330M Sep/2024
Pacira USD 100.65M 4.13M Sep/2024
Perrigo USD 785.9M 34.3M Sep/2024
Pfizer USD 17.69B 2.61B Sep/2024
Prestige Brands USD 167.27M 3.73M Dec/2024
Roche Holding CHF 13.46B 984M Dec/2024
Sanofi 8.8B 2.24B Jun/2024
Sanofi 8.8B 2.24B Jun/2024
Supernus Pharmaceuticals USD 145.41M 7.09M Sep/2024
UCB EUR 1.42B 132M Jun/2024
Zoetis USD 1.32B 95M Dec/2024